DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy.

Int J Endocrinol · 2022 · PMC9715318 · PMID 36467461

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Further analysis showed a clear trend that, among the seven types of thyroid nodules, DPP4 expressed higher in malignant nodules than in benign nodules, especially the most elevated one in MTC nodules, although the difference was not significant ( p > 0.05).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.